In short
Device-related infection is a serious complication that can occur when medical devices implanted in the body become colonized by harmful microorganisms, leading to illness that requires complex treatment and can significantly impact a patient's quality of life.
Key points
- More than half of all healthcare-associated infections—over 1 million cases yearly—are linked to medical devices implanted in patients' bodies.
- Bacteria create protective fortresses called biofilms on devices, making them up to 1,000 times harder to kill with antibiotics than free-floating bacteria.
- Device infection rates have risen 210% over recent decades, increasing faster than device use itself, making prevention and early detection more critical than ever.
- Staphylococcus bacteria from human skin are the most common culprits, which is why strict sterile technique during surgery is essential but still cannot eliminate all risk.
- Infections can appear years after device placement, not just in the immediate post-surgical period, so ongoing vigilance is important throughout a device's lifetime.
- People over 65, those with diabetes or kidney disease, and patients with previous device infections face substantially higher risks and need extra precautions.
- Early recognition of infection symptoms—including redness, warmth, drainage, fever, or chills—and immediate medical attention can prevent life-threatening complications and improve outcomes.
- Most device infections cannot be cured without removing the infected device, as antibiotics alone cannot penetrate biofilms effectively enough to eliminate bacteria.
Who Is at Higher Risk?
Certain groups of people face a greater chance of developing device-related infections due to various factors that weaken the body's ability to fight germs or increase exposure to bacteria. Understanding these risk factors is important because it helps doctors and patients take extra precautions when needed.
Age plays a significant role in infection risk. The occurrence of device-related infection is greatest in people over 65 years of age. As the population ages and more elderly individuals receive medical devices, the overall number of infections is expected to continue rising. Older adults often have weaker immune systems and may have multiple health conditions that further compromise their ability to fight infection.
Several chronic medical conditions increase susceptibility to device infections. Diabetes is a major risk factor because high blood sugar levels can impair the immune system's function and slow wound healing. People with chronic kidney disease, particularly those requiring dialysis, face higher infection risks because their condition often requires frequent needle insertions and their immune systems may be compromised. Heart failure, chronic obstructive pulmonary disease (COPD), and cancer all increase infection risk, as do conditions requiring immunosuppressive medications—drugs that deliberately weaken the immune system, such as corticosteroids or chemotherapy agents.
Previous infections, particularly a history of infection in a prior device, significantly increase the likelihood of infection in a new or replacement device. Patients who have already experienced one device infection are at elevated risk for future infections, possibly because the bacteria that caused the first infection may still be present in surrounding tissues or because the initial infection left lasting damage that makes the area more vulnerable.
Certain medications increase infection risk beyond just immunosuppressants. Anticoagulants—medications that prevent blood clots—are associated with higher infection rates, possibly because bleeding or bruising around the device site can create pockets where bacteria can grow. Antibiotics themselves, while meant to prevent infection, can sometimes backfire by killing off helpful bacteria and allowing resistant strains to flourish.
The complexity of the device and the surgical procedure also matter. More complex systems, such as cardiac resynchronization therapy devices that require multiple leads threaded into the heart, have higher infection rates than simpler single-chamber pacemakers. Procedures that require reoperation—whether to replace a device, add components, or fix problems—carry substantially higher infection risks than first-time placements. Each time doctors operate on the device pocket or manipulate the leads, there is another opportunity for bacteria to contaminate the hardware.
Recognizing the Symptoms
The symptoms of device-related infections can vary widely depending on where the device is located, what type of infection has developed, and how long the infection has been present. Clinical presentation ranges from infections with no obvious symptoms to severe systemic illness that can lead to sepsis—a life-threatening condition where the body's response to infection causes widespread inflammation and organ damage—or septic shock, where blood pressure drops dangerously low.
Local signs of infection at the device site are often the first clue that something is wrong. These signs include redness of the skin around the implant, warmth when you touch the area, swelling, pain or tenderness, and drainage of fluid from the surgical wound. The skin over the device might look inflamed or feel hot compared to surrounding skin. In some cases, the skin may break down, forming an ulceration—an open sore—that exposes the device beneath. The device itself might become visible through the skin or might feel like it is moving more than it should, suggesting the pocket is infected and the tissues are breaking down.
Systemic symptoms indicate the infection has spread beyond the device site into the bloodstream or other parts of the body. Fever is a common systemic symptom, as are chills and sweating. Patients may feel generally unwell, with fatigue, weakness, or body aches. When devices are located in or near the heart, infected bacteria can break off and travel through the bloodstream to other organs, causing embolic phenomena—blockages in blood vessels that can lead to strokes, kidney damage, or other serious complications.
Sometimes infections cause local tissue damage beyond just redness and swelling. The infected device may loosen from its proper position. Wound dehiscence—where the surgical incision reopens—can occur. Components of the device might malfunction or break. For heart valves specifically, infection can cause the valve leaflets to become damaged, leading to heart failure symptoms like shortness of breath and leg swelling.
A particularly challenging aspect of device infections is that they can sometimes be present without causing obvious symptoms, especially in the early stages or when caused by slow-growing bacteria. This means a patient might have a device infection even though they feel fine and have no visible signs of trouble. This is why the onset of signs and symptoms can occur early after implantation, suggesting contamination during surgery, or can be delayed, sometimes appearing months or even years later.
How the Body Changes During Device Infection
Understanding what happens inside the body when a device becomes infected helps explain why these infections are so difficult to treat. The process involves complex interactions between the implanted material, invading microorganisms, and the body's immune and blood clotting systems.
When a foreign object like a medical device is placed in the body, the immune system immediately recognizes it as not belonging there. Even without infection, the body surrounds the implant with immune cells and fibrous tissue in what is called a foreign body response. This response is usually mild and helps isolate the device. However, if bacteria contaminate the device, this same process can inadvertently help the infection by creating an environment where bacteria are partially protected from immune attacks.
The formation of biofilm is central to device infection pathophysiology. Immediately after a device is implanted, proteins from blood and tissue fluid coat its surface. Bacteria that come into contact with this protein layer can stick to it. Once attached, the bacteria begin producing the extracellular polymeric matrix that defines biofilm. Within this biofilm, bacteria behave very differently than when they are floating freely. They grow more slowly, enter dormant states, and activate genes that make them resistant to antibiotics. The biofilm matrix itself acts as a physical barrier that antibiotics struggle to penetrate.
The biofilm may act as a filter, trapping minerals or components from the blood serum. Most of the biofilm volume is actually composed of this extracellular polymeric substance rather than bacterial cells. Microscopic examination reveals that the extracellular material appears either as thin strands connecting cells to each other and to the device surface, or as sheets of amorphous material covering the surface. This architecture makes biofilms both tenacious—extremely difficult to remove—and highly resistant to antimicrobial treatment.
Research has demonstrated just how resistant biofilm bacteria are compared to free-floating bacteria. In laboratory studies, treating biofilm with antibiotic levels far exceeding what would normally kill bacteria resulted in only modest reductions in bacterial counts—a 100-fold decrease—while the same antibiotic dose produced more than a 100-million-fold decrease in free-floating bacteria of the same species. This dramatic difference explains why device infections cannot usually be cured with antibiotics alone.
The host immune system struggles to fight biofilm infections effectively. Immune cells like neutrophils and macrophages—the body's infection-fighting warriors—arrive at the infected device but cannot penetrate the biofilm matrix to reach the bacteria inside. This leads to frustrated phagocytosis, where immune cells continuously try and fail to engulf bacteria, releasing inflammatory chemicals that damage surrounding tissues but don't clear the infection. This chronic inflammation contributes to the loosening of implants, tissue breakdown, and other complications.
The coagulation system—the body's blood clotting mechanism—also becomes involved in device infections. Bacteria and their products can activate clotting, leading to small clots forming on and around the device. These clots can harbor bacteria, protecting them further from antibiotics and immune defenses. In cardiac devices with leads running through blood vessels, these infected clots can break off and travel to other organs, causing serious complications.
For devices like urinary catheters, biofilms may initially contain a single bacterial species, but as the catheter remains in place longer, multiple species colonize it, creating complex multispecies biofilms. Different bacterial species within these biofilms can cooperate, with some species creating conditions that help others survive or producing factors that increase antibiotic resistance for the entire community.
